Señales en vivo de EPIX | Maximiza tus Ganancias con Getagraph.com

COMPRAR 114056 min ago

@ $9.53

Emitido: 12 feb 2024 @ 12:36

Retorno: -30.54%

Señal anterior: feb 8 - 15:49

Señal anterior: Vender

Retorno: -9.50 %

Live Chart Being Loaded With Signals

Commentary (1 may 2024 @ 16:00):

Stats
Volumen de hoy	36 613.00
Volumen promedio	123 749
Capitalización de mercado	292.86M
EPS	$0 ( 2024-02-13 )
Próxima fecha de ganancias	( $-0.190 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-11.22
ATR14	$0.0990 (1.49%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-24	Glickman Richard M	Buy	3 750	Common Shares
2024-04-24	Glickman Richard M	Sell	3 750	Options
2024-04-05	Virsik Peter	Sell	694	Common Shares
2024-03-25	Zweifach Sanford S	Buy	50 000	Options
2024-03-25	Thorell Marella	Buy	50 000	Options

INSIDER POWER
74.69
Last 100 transactions
Buy: 6 897 304 \| Sell: 769 682

Volumen Correlación

Largo: -0.27 (neutral)

Corto: -0.07 (neutral)

Signal:(45.385) Neutral

ESSA Pharma Inc Correlación

10 Correlaciones Más Positivas
GOODM	0.808

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ESSA Pharma Inc Correlación - Moneda/Commodity

0.75
( moderate )

0.80
( moderate )

0.81
( strong )

0.45
( neutral )

-0.72
( moderate negative )

ESSA Pharma Inc Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-118 491 (0.00 %)
EPS:	$-0.600

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-118 491 (0.00 %)
EPS:	$-0.600

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-121 787 (0.00 %)
EPS:	$-0.800

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.960

Financial Reports:

No articles found.

ESSA Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.